Dermavant Archives -

Roivant group company Dermavant has made the transition to a commercial-stage company after getting FDA approval for Vtama,

Dermavant claims its first approval as FDA clears psoriasis drug

https://pharmaphorum.com/news/dermavant-claims-its-first-approval-as-fda-clears-psoriasis-drug/

Dermavant is in line to make some big payments to GlaxoSmithKline if its topical psoriasis drug tapinarof reaches

Dermavant raises $200m to ease launch of Otezla rival tapinarof

https://pharmaphorum.com/news/dermavant-raises-200m-to-ease-launch-of-otezla-rival-tapinarof/

Just two years after buying rights to psoriasis candidate tapinarof from GlaxoSmithKline, Swiss biotech Dermavant says it could

Phase 3 wins put Dermavant closer to filing Otezla rival tapinarof

https://pharmaphorum.com/news/phase-3-wins-put-dermavant-closer-to-filing-otezla-rival-tapinarof/

Dermavant